{
    "eid": "2-s2.0-85140349808",
    "title": "High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (miscellaneous)",
            "@code": "2701",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Esophageal cancer",
        "Intensity-modulated proton therapy",
        "Intensity-modulated radiotherapy",
        "Squamous cell carcinoma",
        "Survival",
        "Toxicity"
    ],
    "authors": [
        "Chawalit Lertbutsayanukul",
        "Sarin Kitpanit",
        "Danita Kannarunimit",
        "Chakkapong Chakkabat",
        "Sornjarod Oonsiri",
        "Kullathorn Thephamongkhol",
        "Putipun Puataweepong",
        "Kanyarat Katanyoo",
        "Jirasak Sukhaboon",
        "Chokaew Tovanabut",
        "Sirikanya Chongsathientham",
        "Pornravee Treeratsapanich",
        "Jirarat Soonthornrak",
        "Anussara Prayongrat"
    ],
    "citedby-count": 0,
    "ref-count": 31,
    "ref-list": [
        "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries",
        "Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01)",
        "INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy",
        "Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial",
        "Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781",
        "Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer",
        "Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma",
        "Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy",
        "High vs. Low radiation dose of concurrent chemoradiotherapy for esophageal carcinoma with modern radiotherapy techniques: a meta-analysis. Front",
        "High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma",
        "Randomized study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer (ARTDECO Study)",
        "Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma",
        "Analysis of intensity-modulated radiation therapy (IMRT), proton and 3D conformal radiotherapy (3D-CRT) for reducing perioperative cardiopulmonary complications in esophageal cancer patients",
        "Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy",
        "Comparing proton beam to intensity modulated radiation therapy planning in esophageal cancer",
        "Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer",
        "Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose-volume histogram analysis",
        "Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal cancer: a retrospective, single-institutional analysis",
        "Treatment-related lymphopenia predicts pathologic complete response and recurrence in esophageal squamous cell carcinoma undergoing neoadjuvant chemoradiotherapy",
        "Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy",
        "The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy",
        "Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer",
        "Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy",
        "Proton beam therapy combined with concurrent chemotherapy for esophageal cancer",
        "Clinical results of proton beam therapy for esophageal cancer: multicenter retrospective study in Japan",
        "Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer",
        "Validation of a robust strategy for proton spot scanning for oesophageal cancer in the presence of anatomical changes",
        "A study to investigate the influence of cardiac motion on the robustness of pencil beam scanning proton plans in oesophageal cancer",
        "Acute toxicities and short-term patient outcomes after intensity-modulated proton beam radiation therapy or intensity-modulated photon radiation therapy for esophageal carcinoma: a Mayo Clinic experience",
        "Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience",
        "Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60029487",
            "affilname": "National Cancer Institute Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029487",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020352",
            "affilname": "Vajira Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020352",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chantaburi",
            "@id": "128780223",
            "affilname": "Chanthaburi Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/128780223",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "125796220",
            "affilname": "Chulaphorn Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125796220",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Lopburi",
            "@id": "101521982",
            "affilname": "Lopburi Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101521982",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chonburi",
            "@id": "100826489",
            "affilname": "Chonburi Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100826489",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Thailand Science Research and Innovation Fund Chulalongkorn University CU_FRB65_hea"
    ]
}